These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22815786)

  • 41. [Research on the effect of statins on insulin secretion from pancreatic islet in rats and its mechanisms].
    Chang BC; Zheng MY; Shan CY; Yang JH; Wang Y; Ren HZ; Chen LM; Fang PH
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):393-6. PubMed ID: 21624221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time-dependent effect of statins on platelet function in hypercholesterolaemia.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Angori P; Auteri A; Bruni F
    Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
    Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
    Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation.
    Fukuda K; Matsumura T; Senokuchi T; Ishii N; Kinoshita H; Yamada S; Murakami S; Nakao S; Motoshima H; Kondo T; Kukidome D; Kawasaki S; Kawada T; Nishikawa T; Araki E
    Biochem Biophys Res Commun; 2015 Jan; 457(1):23-30. PubMed ID: 25529449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
    Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA
    Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
    Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
    Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors.
    Zineh I; Luo X; Welder GJ; Debella AE; Wessel TR; Arant CB; Schofield RS; Chegini N
    Pharmacotherapy; 2006 Mar; 26(3):333-40. PubMed ID: 16503719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.
    Kleemann R; Verschuren L; de Rooij BJ; Lindeman J; de Maat MM; Szalai AJ; Princen HM; Kooistra T
    Blood; 2004 Jun; 103(11):4188-94. PubMed ID: 14976045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA; Huang Q; Tesfamariam B
    Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levels.
    Wilson K; Marriott J; Fuller S; Lacey L; Gillen D
    Pharmacoeconomics; 2003; 21 Suppl 1():1-11. PubMed ID: 12648030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toward a role for statins in immunomodulation.
    Mach F
    Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.
    Mc Donnell CG; Shorten G; Van Pelt FN
    Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
    Kalonia H; Kumar P; Kumar A
    Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts.
    Stein SH; Dean IN; Rawal SY; Tipton DA
    J Periodontal Res; 2011 Aug; 46(4):483-90. PubMed ID: 21463327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.